Shareholders Win Cert. In Suit Over Matrixx Cold Medicine
A group of shareholders won class certification Monday in an 8-year-old Arizona suit alleging Matrixx Initiatives Inc. violated securities laws by concealing reports that cold medication Zicam caused a potentially permanent...To view the full article, register now.
Already a subscriber? Click here to view full article